Insufficient scRNA-seq data for expression of PRSS53 at single-cell level.
Insufficient scRNA-seq data for expression of PRSS53 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| kidney | 100% | 290.15 | 89 / 89 | 24% | 0.46 | 212 / 901 |
| brain | 91% | 303.40 | 2402 / 2642 | 21% | 0.31 | 148 / 705 |
| lung | 100% | 325.30 | 576 / 578 | 12% | 0.18 | 133 / 1155 |
| uterus | 100% | 462.32 | 170 / 170 | 8% | 0.15 | 37 / 459 |
| skin | 100% | 470.23 | 1808 / 1809 | 8% | 0.11 | 38 / 472 |
| liver | 100% | 1038.86 | 226 / 226 | 7% | 0.11 | 30 / 406 |
| esophagus | 98% | 340.03 | 1423 / 1445 | 9% | 0.13 | 16 / 183 |
| pancreas | 99% | 225.11 | 326 / 328 | 7% | 0.10 | 13 / 178 |
| breast | 100% | 295.31 | 459 / 459 | 5% | 0.09 | 59 / 1118 |
| bladder | 100% | 436.67 | 21 / 21 | 5% | 0.08 | 24 / 504 |
| ovary | 100% | 414.64 | 180 / 180 | 4% | 0.06 | 16 / 430 |
| adrenal gland | 94% | 143.77 | 242 / 258 | 9% | 0.14 | 21 / 230 |
| intestine | 100% | 403.44 | 965 / 966 | 2% | 0.03 | 9 / 527 |
| stomach | 99% | 238.91 | 356 / 359 | 2% | 0.03 | 6 / 286 |
| thymus | 100% | 296.46 | 651 / 653 | 1% | 0.01 | 7 / 605 |
| prostate | 100% | 412.41 | 245 / 245 | 1% | 0.02 | 4 / 502 |
| spleen | 100% | 361.27 | 241 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 609.64 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 100% | 305.64 | 1201 / 1204 | 0% | 0 | 0 / 0 |
| heart | 82% | 124.82 | 702 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 81% | 150.01 | 755 / 929 | 0% | 0 | 0 / 0 |
| muscle | 64% | 78.00 | 516 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.03 | 1 / 45 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006508 | Biological process | proteolysis |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005515 | Molecular function | protein binding |
| GO_0004252 | Molecular function | serine-type endopeptidase activity |
| Gene name | PRSS53 |
| Protein name | Serine protease 53 (EC 3.4.21.-) (Polyserine protease 3) (Polyserase-3) |
| Synonyms | |
| Description | FUNCTION: In vitro can degrade the fibrinogen alpha chain of as well as pro-urokinase-type plasminogen activator. . |
| Accessions | ENST00000280606.7 Q2L4Q9 |